Singapore markets closed
  • Straits Times Index

    3,157.97
    -4.53 (-0.14%)
     
  • Nikkei

    28,948.73
    -9.83 (-0.03%)
     
  • Hang Seng

    28,842.13
    +103.25 (+0.36%)
     
  • FTSE 100

    7,134.06
    +45.88 (+0.65%)
     
  • BTC-USD

    35,717.29
    -1,141.37 (-3.10%)
     
  • CMC Crypto 200

    924.19
    -17.62 (-1.87%)
     
  • S&P 500

    4,247.44
    +8.26 (+0.19%)
     
  • Dow

    34,479.60
    +13.36 (+0.04%)
     
  • Nasdaq

    14,069.42
    +49.09 (+0.35%)
     
  • Gold

    1,879.50
    -16.90 (-0.89%)
     
  • Crude Oil

    70.78
    +0.49 (+0.70%)
     
  • 10-Yr Bond

    1.4620
    +0.0030 (+0.21%)
     
  • FTSE Bursa Malaysia

    1,575.16
    -4.74 (-0.30%)
     
  • Jakarta Composite Index

    6,095.50
    -12.04 (-0.20%)
     
  • PSE Index

    6,907.79
    +32.08 (+0.47%)
     

Transcat Reports Record Revenue, Operating Income and Cash Flow for Fourth Quarter and Full Year Fiscal 2021

  • Oops!
    Something went wrong.
    Please try again later.
·17-min read
  • Oops!
    Something went wrong.
    Please try again later.
  • Consolidated fourth quarter revenue of $48.8 million up 6.6% from prior year; full year revenue slightly above prior year

  • Service segment fourth quarter organic revenue grew 10% and gross margin expanded 500 basis points to 33.9%

  • Service segment surpassed $100 million in revenue and 30% gross margin milestones for the full year

  • Record full year operating income and operating cash flow of $11.1 million and $23.6 million, respectively

Transcat, Inc. (Nasdaq: TRNS) ("Transcat" or the "Company"), a leading provider of accredited calibration, repair, inspection and laboratory instrument services and value-added distributor of professional grade handheld test, measurement and control instrumentation, today reported financial results for its fourth quarter and fiscal year ended March 27, 2021 ("fiscal 2021"). Results include the previously reported acquisitions of TTE Laboratories, Inc. (referred to as "pipettes.com") effective February 21, 2020 and the acquisition of Bio Tek Services, Inc. ("Bio Tek") effective December 16, 2020.

"Our fourth quarter results were stronger than expected and allowed us to achieve record fourth quarter and full year revenue, operating income and cash flow, a remarkable achievement in the midst of the global COVID-19 pandemic," commented Lee D. Rudow, President and CEO. "Our Service segment delivered another excellent quarter, growing revenue 15.8% and increasing gross margin by 500 basis points from the prior-year period. We reported double-digit organic revenue growth of 10% as our strategy to capture share in highly-regulated end markets, including Life Sciences, continues to serve us well. Our gross margin improvement was driven by technician productivity, operating leverage on our fixed costs and strong performances from our recent acquisitions."

"We were encouraged by improvement in our Distribution business, with fourth quarter revenue declining 4.6% to $19.8 million, the best quarterly result of fiscal 2021. Overall, our Service segment performance drove fourth quarter consolidated operating income of $4.5 million, exceeding our expectations and growing 21% from prior year. We also achieved two important Service segment milestones, surpassing $100 million in revenue and 30% gross margin for the full year."

He added, "We generated cash flow from operations of $23.6 million for the full year, a company record and double the cash we generated in fiscal 2020. We used our cash to pay down debt, fund technology investments and execute our acquisition strategy. In April 2021, we acquired Upstate Metrology, a Rochester, NY-based calibration service provider with approximately $1 million in annual revenue. We plan to leverage our current infrastructure and consolidate the business into our main Rochester lab."

Fourth Quarter Fiscal 2021 Review (Results compared with the fourth quarter of fiscal 2020)

($ in thousands)

Change

FY21 Q4

FY20 Q4

$'s

%

Service Revenue

$

28,977

$

25,016

$

3,961

15.8

%

Distribution Sales

19,785

20,746

(961

)

(4.6

%)

Revenue

$

48,762

$

45,762

$

3,000

6.6

%

Gross Profit

$

13,970

$

12,053

$

1,917

15.9

%

Gross Margin

28.6

%

26.3

%

Operating Income

$

4,512

$

3,742

$

770

20.6

%

Operating Margin

9.3

%

8.2

%

Net Income

$

3,208

$

2,493

$

715

28.7

%

Net Margin

6.6

%

5.4

%

Adjusted EBITDA*

$

7,302

$

5,611

$

1,691

30.1

%

Adjusted EBITDA* Margin

15.0

%

12.3

%

*See Note 1 on page 5 for a description of this non-GAAP financial measure and page 10 for the Adjusted EBITDA Reconciliation table.

Despite the ongoing impact from the COVID-19 pandemic, consolidated revenue of $48.8 million was up 6.6% year-over-year. Consolidated gross profit increased 15.9% and gross margin improved by 230 basis points on Service segment margin expansion. Operating expenses increased approximately $1.1 million, or 14%, driven by incremental expenses from acquired businesses, investments in technology and $0.3 million of severance expense. The effective tax rate was 23.6% for the quarter compared with 26.6% for the previous fiscal year’s fourth quarter. Net income per diluted share increased 27% to $0.42 from $0.33.

Service segment delivers record quarterly results

Represents the accredited calibration, repair, inspection and laboratory instrument services business (59% of total revenue for the fourth quarter of fiscal 2021).

($ in thousands)

Change

FY21 Q4

FY20 Q4

$'s

%

Service Segment Revenue

$

28,977

$

25,016

$

3,961

15.8

%

Gross Profit

$

9,811

$

7,236

$

2,575

35.6

%

Gross Margin

33.9

%

28.9

%

Operating Income

$

4,379

$

2,609

$

1,770

67.8

%

Operating Margin

15.1

%

10.4

%

Adjusted EBITDA*

$

6,276

$

3,937

$

2,339

59.4

%

Adjusted EBITDA* Margin

21.7

%

15.7

%

*See Note 1 on page 5 for a description of this non-GAAP financial measure and page 10 for the Adjusted EBITDA Reconciliation table.

Service segment revenue increased 15.8% to a record $29.0 million and included $1.4 million of incremental revenue from acquisitions. Organic revenue growth was 10.0% and was driven by continued market share gains and an easier comparison over the prior-year quarter, as we began to feel the impact of the COVID-19 pandemic toward the second half of March 2020.

Service segment gross margin expanded 500 basis points and was driven by technician productivity, operating leverage on our fixed costs and accretive acquisition margins.

Distribution segment fourth quarter sales reached highest level of fiscal 2021

Represents the sale and rental of new and used professional grade handheld test, measurement and control instrumentation (41% of total revenue for the fourth quarter of fiscal 2021).

($ in thousands)

Change

FY21 Q4

FY20 Q4

$'s

%

Distribution Segment Sales

$

19,785

$

20,746

$

(961

)

(4.6

%)

Gross Profit

$

4,159

$

4,817

$

(658

)

(13.7

%)

Gross Margin

21.0

%

23.2

%

Operating Income

$

133

$

1,133

$

(1,000

)

(88.3

%)

Operating Margin

0.7

%

5.5

%

Adjusted EBITDA*

$

1,026

$

1,674

$

(648

)

(38.7

%)

Adjusted EBITDA* Margin

5.2

%

8.1

%

*See Note 1 on page 5 for a description of this non-GAAP financial measure and page 10 for the Adjusted EBITDA Reconciliation table.

Distribution segment sales continued to be negatively impacted by the lingering effects of the COVID-19 pandemic, however, the business saw sequential improvement from the previous quarter and revenue hit $19.8 million, the highest quarterly total of the year. Rental revenue of $1.4 million was up 11% over the prior-year period. Distribution segment gross profit reflected lower volume from core product sales and reduced co-operative advertising and rebate programs as vendors reduced these programs to lower their costs.

Full-Year Fiscal 2021 Review (Results compared with fiscal 2020)

($ in thousands)

Change

FY21

FY20

$'s

%

Service Revenue

$

101,274

$

93,003

$

8,271

8.9

%

Distribution Sales

72,061

80,096

(8,035

)

(10.0

%)

Revenue

$

173,335

$

173,099

$

236

0.1

%

Gross Profit

$

46,118

$

42,478

$

3,640

8.6

%

Gross Margin

26.6

%

24.5

%

Operating Income

$

11,073

$

10,850

$

223

2.1

%

Operating Margin

6.4

%

6.3

%

Net Income

$

7,791

$

8,067

$

(276

)

(3.4

%)

Net Margin

4.5

%

4.7

%

Adjusted EBITDA*

$

20,575

$

18,407

$

2,168

11.8

%

Adjusted EBITDA* Margin

11.9

%

10.6

%

*See Note 1 on page 5 for a description of this non-GAAP financial measure and page 10 for the Adjusted EBITDA Reconciliation table.

Consolidated revenue of $173.3 million was up modestly from the prior year. Service Segment revenue reached a record $101.3 million, up nearly 9%, while Distribution revenue declined approximately 10% due to the COVID-19 pandemic.

Consolidated gross margin grew 210 basis points and was driven by the Service gross margin improvement. Total operating expenses increased 10.8% to $35.0 million as the Company continued to invest in technology initiatives and acquisitions. As a result, operating income reached a record $11.1 million, up 2.1% from the prior year.

The effective tax rate for fiscal 2021 was 21.9% compared with 17.1% in the prior fiscal year. The lower tax rate in fiscal 2020 was aided by higher discrete income tax benefits related to share-based awards due to stock option exercise activity. Fiscal year 2021 net income per diluted share was $1.03 compared with $1.08.

Balance Sheet and Cash Flow Overview

Fiscal 2021 net cash provided by operations was $23.6 million and was used to fund capital expenditures of $6.6 million, acquisition payments and debt repayment. The capital investments were focused on technology infrastructure, organic growth opportunities and rental pool assets.

At March 27, 2021, the Company had $31.1 million available for borrowing under its secured revolving credit facility. Total debt of $19.6 million was down $10.7 million from fiscal 2020 year-end. The Company’s leverage ratio, as defined in the credit agreement, was 0.94 at March 27, 2021, compared with 1.53 at fiscal 2020 year-end.

Outlook

Mr. Rudow concluded, "I am incredibly proud of the performance and dedication of the entire Transcat team in the fourth quarter and throughout fiscal 2021 as we navigated the most challenging operating environment in recent history. We enter fiscal 2022 with a strong balance sheet, sustainable Service segment gross margins and an active M&A pipeline. We are confident that our disciplined focus on highly-regulated end markets and our new customer pipeline positions us well for continued strong organic growth.

"For the first quarter of fiscal 2022, we expect Service organic growth to be similar to what we achieved in the fourth quarter of fiscal 2021. We expect improvement in Service gross margin, but not to the same degree we experienced in fiscal 2021, largely due to more difficult technician productivity comparisons and the recent anniversary of our acquisition of pipettes.com, which occurred in February 2020. Distribution is expected to achieve high double-digit growth in the first quarter on modestly improving trends and a prior-year comparison that includes low levels of demand due to the onset of the COVID-19 pandemic. Total operating expenses are expected to be similar to the trailing fourth quarter of 2021."

Transcat expects its income tax rate to range between 20% and 22% in fiscal 2022. This estimate includes Federal, various state, and Canadian income taxes and reflects discrete tax accounting associated with share-based payment awards.

The Company anticipates total capital expenditures to be approximately $7.5 million to $8.5 million in fiscal 2022, with the majority of the capital expenditures planned for growth-oriented opportunities within both of its operating segments.

Webcast and Conference Call

Transcat will host a conference call and webcast on Wednesday, May 19, 2021 at 11:00 a.m. Eastern Time. Management will review the financial and operating results for the fourth quarter and full fiscal year, as well as the Company’s strategy and outlook. A question and answer session will follow the formal discussion. The review will be accompanied by a slide presentation, which will be available at www.transcat.com/investor-relations. The conference call can be accessed by calling (201) 689-8471. Alternatively, the webcast can be monitored at www.transcat.com/investor-relations.

A telephonic replay will be available from 2:00 p.m. Eastern Time on the day of the call through Wednesday, May 26, 2021. To listen to the archived call, dial (412) 317-6671 and enter conference ID number 13718348, or access the webcast replay at www.transcat.com/investor-relations, where a transcript will be posted once available.

NOTE 1 – Non-GAAP Financial Measures

In addition to reporting net income, a U.S. generally accepted accounting principle ("GAAP") measure, we present Adjusted EBITDA (earnings before interest, income taxes, depreciation and amortization, non-cash stock compensation expense, restructuring expense, and non-cash loss on sale of building), which is a non-GAAP measure. The Company’s management believes Adjusted EBITDA is an important measure of operating performance because it allows management, investors and others to evaluate and compare the performance of its core operations from period to period by removing the impact of the capital structure (interest), tangible and intangible asset base (depreciation and amortization), taxes, stock-based compensation expense and other items, which is not always commensurate with the reporting period in which it is included. As such, the Company uses Adjusted EBITDA as a measure of performance when evaluating its business segments and as a basis for planning and forecasting. Adjusted EBITDA is not a measure of financial performance under GAAP and is not calculated through the application of GAAP. As such, it should not be considered as a substitute for the GAAP measure of net income and, therefore, should not be used in isolation of, rather in conjunction with, the GAAP measure. Adjusted EBITDA, as presented, may produce results that vary from the GAAP measure and may not be comparable to a similarly defined non-GAAP measure used by other companies. See the attached Adjusted EBITDA Reconciliation table below.

ABOUT TRANSCAT

Transcat, Inc. is a leading provider of accredited calibration, repair, inspection and laboratory instrument services. The Company is focused on providing best-in-class services and products to highly regulated industries, particularly the Life Science industry, which includes pharmaceutical, biotechnology, medical device and other FDA-regulated businesses; as well as aerospace and defense, and energy and utilities. Transcat provides periodic on-site services, mobile calibration services, pickup and delivery, in-house services at its 22 Calibration Service Centers strategically located across the United States, Puerto Rico and Canada, and services at 20 imbedded customer-site locations. The breadth and depth of measurement parameters addressed by Transcat’s ISO/IEC 17025 scopes of accreditation are believed to be the best in the industry.

Transcat also operates as a leading value-added distributor that markets, sells and rents new and used national and proprietary brand instruments to customers primarily in North America. The Company believes its combined Service and Distribution segment offerings, experience, technical expertise and integrity create a unique and compelling value proposition for its customers.

Transcat’s strategy is to leverage the complementary nature of its two operating segments, its comprehensive service capabilities, strong brand, enhanced e-commerce capabilities and leading distribution platform to drive organic sales growth. The Company will also look to expand its addressable calibration market through acquisitions and capability investments to further realize the inherent leverage of its business model.

More information about Transcat can be found at: Transcat.com.

Safe Harbor Statement

This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are not statements of historical fact and thus are subject to risks, uncertainties and assumptions. Forward-looking statements are identified by words such as "expects," "estimates," "projects," "anticipates," "believes," "could," "plans," "aims" and other similar words. All statements addressing operating performance, events or developments that Transcat expects or anticipates will occur in the future, including but not limited to statements relating to anticipated revenue, profit margins, the impact of and the Company’s response to the COVID-19 pandemic, the commercialization of software projects, sales operations, capital expenditures, cash flows, operating income, growth strategy, segment growth, potential acquisitions, integration of acquired businesses, market position, customer preferences, outlook and changes in market conditions in the industries in which Transcat operates are forward-looking statements. Forward-looking statements should be evaluated in light of important risk factors and uncertainties. These risk factors and uncertainties include those more fully described in Transcat’s Annual Report and Quarterly Reports filed with the Securities and Exchange Commission, including under the heading entitled "Risk Factors." Should one or more of these risks or uncertainties materialize, or should any of the Company’s underlying assumptions prove incorrect, actual results may vary materially from those currently anticipated. In addition, undue reliance should not be placed on the Company’s forward-looking statements, which speak only as of the date they are made. Except as required by law, the Company disclaims any obligation to update, correct or publicly announce any revisions to any of the forward-looking statements contained in this news release, whether as the result of new information, future events or otherwise.

FINANCIAL TABLES FOLLOW.

The Company plans on timely filing its Annual Report on Form 10-K before the required filing date.

TRANSCAT, INC.

CONSOLIDATED STATEMENTS OF INCOME

(In Thousands, Except Per Share Amounts)

Fourth Quarter Ended

Fiscal Year Ended

(Unaudited)

(Unaudited)

March 27,

March 28,

March 27,

March 28,

2021

2020

2021

2020

Service Revenue

$

28,977

$

25,016

$

101,274

$

93,003

Distribution Sales

19,785

20,746

72,061

80,096

Total Revenue

48,762

45,762

173,335

173,099

Cost of Service Revenue

19,166

17,780

70,579

69,517

Cost of Distribution Sales

15,626

15,929

56,638

61,104

Total Cost of Revenue

34,792

33,709

127,217

130,621

Gross Profit

13,970

12,053

46,118

42,478

Selling, Marketing and Warehouse Expenses

4,703

4,819

17,743

17,985

General and Administrative Expenses

4,755

3,492

17,302

13,643

Total Operating Expenses

9,458

8,311

35,045

31,628

Operating Income

4,512

3,742

11,073

10,850

Interest and Other Expense, net

312

344

1,091

1,120

Income Before Income Taxes

4,200

3,398

9,982

9,730

Provision for Income Taxes

992

905

2,191

1,663

Net Income

$

3,208

$

2,493

$

7,791

$

8,067

Basic Earnings Per Share

$

0.43

$

0.34

$

1.05

$

1.10

Average Shares Outstanding

7,447

7,379

7,423

7,331

Diluted Earnings Per Share

$

0.42

$

0.33

$

1.03

$

1.08

Average Shares Outstanding

7,611

7,569

7,548

7,487

TRANSCAT, INC.

CONSOLIDATED BALANCE SHEETS

(In Thousands, Except Share and Per Share Amounts)

(Unaudited)

March 27,

March 28,

2021

2020

ASSETS

Current Assets:

Cash

$

560

$

499

Accounts Receivable, less allowance for doubtful accounts of $526

and $480 as of March 27, 2021 and March 28, 2020, respectively

33,950

30,952

Other Receivables

428

1,132

Inventory, net

11,636

14,180

Prepaid Expenses and Other Current Assets

2,354

1,697

Total Current Assets

48,928

48,460

Property and Equipment, net

22,203

20,833

Goodwill

43,272

41,540

Intangible Assets, net

7,513

7,977

Right to Use Asset, net

9,392

8,593

Other Assets

808

719

Total Assets

$

132,116

$

128,122

LIABILITIES AND SHAREHOLDERS' EQUITY

Current Liabilities:

Accounts Payable

$

12,276

$

11,947

Accrued Compensation and Other Liabilities

10,417

6,907

Income Taxes Payable

382

86

Current Portion of Long-Term Debt

2,067

1,982

Total Current Liabilities

25,142

20,922

Long-Term Debt

17,494

28,362

Deferred Tax Liabilities

3,201

3,025

Lease Liabilities

7,958

6,832

Other Liabilities

3,243

1,894

Total Liabilities

57,038

61,035

Shareholders' Equity:

Common Stock, par value $0.50 per share, 30,000,000 shares authorized:

7,458,251 and 7,381,180 shares issued and outstanding

as of March 27, 2021, and March 28, 2020, respectively

3,729

3,691

Capital in Excess of Par Value

19,287

17,929

Accumulated Other Comprehensive Loss

(451

)

(1,010

)

Retained Earnings

52,513

46,477

Total Shareholders' Equity

75,078

67,087

Total Liabilities and Shareholders' Equity

$

132,116

$

128,122

TRANSCAT, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In Thousands)

For Fiscal Years Ended

(Unaudited)

March 27,

March 28,

2021

2020

Cash Flows from Operating Activities:

Net Income

$

7,791

$

8,067

Adjustments to Reconcile Net Income to Net Cash Provided

by Operating Activities:

Net Loss on Disposal of Property and Equipment

136

460

Deferred Income Taxes

176

575

Depreciation and Amortization

7,580

6,659

Provision for Accounts Receivable and Inventory Reserves

636

371

Stock-Based Compensation

1,513

884

Changes in Assets and Liabilities:

Accounts Receivable and Other Receivables

(1,796

)

(3,303

)

Inventory

2,724

875

Prepaid Expenses and Other Assets

(725

)

(467

)

Accounts Payable

329

(2,767

)

Accrued Compensation and Other Liabilities

4,943

307

Income Taxes Payable

332

(100

)

Net Cash Provided by Operating Activities

23,639

11,561

Cash Flows from Investing Activities:

Purchase of Property and Equipment

(6,617

)

(6,579

)

Proceeds from Sale of Property and Equipment

17

184

Business Acquisitions, net of cash acquired

(3,551

)

(12,983

)

Payment of Contingent Consideration & Holdbacks Related to Business Acquisitions

-

(864

)

Net Cash Used in Investing Activities

(10,151

)

(20,242

)

Cash Flows from Financing Activities:

Repayment of Revolving Credit Facility, net

(8,801

)

11,241

Repayments of Term Loan

(1,982

)

(1,899

)

Issuance of Common Stock

1,177

1,727

Repurchase of Common Stock

(3,049

)

(2,822

)

Net Cash Used in Financing Activities

(12,655

)

8,247

Effect of Exchange Rate Changes on Cash

(772

)

145

Net Increase (Decrease) in Cash

61

(289

)

Cash at Beginning of Period

499

788

Cash at End of Period

$

560

$

499

TRANSCAT, INC.

Adjusted EBITDA Reconciliation Table

(Dollars in thousands)

(Unaudited)

Fiscal 2021

Q1

Q2

Q3

Q4

YTD

Net Income

$

798

$

2,024

$

1,761

$

3,208

$

7,791

+ Interest Expense

224

233

203

190

850

+ Other Expense / (Income)

19

84

16

122

...

+ Tax Provision

(77

)

737

539

992

2,191

Operating Income

$

964

$

3,078

$

2,519

$

4,512

$

11,073

+ Depreciation & Amortization

1,871

1,864

1,861

1,984

7,580

+ Restructuring Expense

360

-

-

290

650

+ Other (Expense) / Income

(19

)

(85

)

(15

)

(122

)

(241

)

+ Noncash Stock Compensation

312

366

197

638

1,513

Adjusted EBITDA

$

3,488

$

5,223

$

4,562

$

7,302

$

20,575

Segment Breakdown

Service Operating Income

$

1,129

$

2,977

$

1,956

$

4,379

$

10,441

+ Depreciation & Amortization

1,394

1,359

1,372

1,472

5,597

+ Restructuring Expense

193

-

-

156

349

+ Other (Expense) / Income

(15

)

(57

)

(8

)

(82

)

(162

)

+ Noncash Stock Compensation

162

196

126

351

835

Service Adjusted EBITDA

$

2,863

$

4,475

$

3,446

$

6,276

$

17,060

Distribution Operating Income

$

(165

)

$

101

$

563

$

133

$

632

+ Depreciation & Amortization

477

505

489

512

1,983

+ Restructuring Expense

167

-

-

134

301

+ Other (Expense) / Income

(4

)

(28

)

(7

)

(40

)

(79

)

+ Noncash Stock Compensation

150

170

71

287

678

Distribution Adjusted EBITDA

$

625

$

748

$

1,116

$

1,026

$

3,515

Fiscal 2020

Q1

Q2

Q3

Q4

YTD

Net Income

$

1,718

$

2,379

$

1,477

$

2,493

$

8,067

+ Interest Expense

244

243

216

231

934

+ Other Expense / (Income)

41

54

(22

)

113

186

+ Tax Provision

(45

)

383

420

905

1,663

Operating Income

$

1,958

$

3,059

$

2,091

$

3,742

$

10,850

+ Depreciation & Amortization

1,622

1,681

1,648

1,707

6,658

+ Other (Expense) / Income

159

(54

)

22

(112

)

15

+ Noncash Stock Compensation

203

102

305

274

884

Adjusted EBITDA

$

3,942

$

4,788

$

4,066

$

5,611

$

18,407

Segment Breakdown

Service Operating Income

$

738

$

1,837

$

488

$

2,609

$

5,672

+ Depreciation & Amortization

1,220

1,246

1,206

1,257

4,929

+ Other (Expense) / Income

77

(38

)

13

(72

)

(20

)

+ Noncash Stock Compensation

112

56

159

143

470

Service Adjusted EBITDA

$

2,147

$

3,101

$

1,866

$

3,937

$

11,051

Distribution Operating Income

$

1,220

$

1,222

$

1,603

$

1,133

$

5,178

+ Depreciation & Amortization

401

436

442

450

1,729

+ Other (Expense) / Income

83

(17

)

9

(40

)

35

+ Noncash Stock Compensation

91

46

146

131

414

Distribution Adjusted EBITDA

$

1,795

$

1,687

$

2,200

$

1,674

$

7,356

TRANSCAT, INC.

Additional Information - Business Segment Data

(Dollars in thousands)

(Unaudited)

Change

SERVICE

FY 2021 Q4

FY 2020 Q4

$'s

%

Service Revenue

$

28,977

$

25,016

$

3,961

15.8

%

Cost of Revenue

19,166

17,780

1,386

7.8

%

Gross Profit

$

9,811

$

7,236

$

2,575

35.6

%

Gross Margin

33.9

%

28.9

%

Selling, Marketing & Warehouse Expenses

$

2,639

$

2,563

$

76

3.0

%

General and Administrative Expenses

2,793

2,064

729

35.3

%

Operating Income

$

4,379

$

2,609

$

1,770

67.8

%

% of Revenue

15.1

%

10.4

%

Change

DISTRIBUTION

FY 2021 Q4

FY 2020 Q4

$'s

%

Distribution Sales

$

19,785

$

20,746

$

(961

)

(4.6

%)

Cost of Sales

15,626

15,929

(303

)

(1.9

%)

Gross Profit

$

4,159

$

4,817

$

(658

)

(13.7

%)

Gross Margin

21.0

%

23.2

%

Selling, Marketing & Warehouse Expenses

$

2,064

$

2,256

$

(192

)

(8.5

%)

General and Administrative Expenses

1,962

1,428

534

37.4

%

Operating Income

$

133

$

1,133

$

(1,000

)

(88.3

%)

% of Sales

0.7

%

5.5

%

Change

TOTAL

FY 2021 Q4

FY 2020 Q4

$'s

%

Total Revenue

$

48,762

$

45,762

$

3,000

6.6

%

Total Cost of Revenue

34,792

33,709

1,083

3.2

%

Gross Profit

$

13,970

$

12,053

$

1,917

15.9

%

Gross Margin

28.6

%

26.3

%

Selling, Marketing & Warehouse Expenses

$

4,703

$

4,819

$

(116

)

(2.4

%)

General and Administrative Expenses

4,755

3,492

1,263

36.2

%

Operating Income

$

4,512

$

3,742

$

770

20.6

%

% of Revenue

9.3

%

8.2

%

TRANSCAT, INC.

Additional Information - Business Segment Data

(Dollars in thousands)

(Unaudited)

Change

SERVICE

FY 2021 YTD

FY 2020 YTD

$'s

%

Service Revenue

$

101,274

$

93,003

$

8,271

8.9

%

Cost of Revenue

70,579

69,517

1,062

1.5

%

Gross Profit

$

30,695

$

23,486

$

7,209

30.7

%

Gross Margin

30.3

%

25.3

%

Selling, Marketing & Warehouse Expenses

$

9,941

$

9,507

$

434

4.6

%

General and Administrative Expenses

10,313

8,307

2,006

24.1

%

Operating Income

$

10,441

$

5,672

$

4,769

84.1

%

% of Revenue

10.3

%

6.1

%

Change

DISTRIBUTION

FY 2021 YTD

FY 2020 YTD

$'s

%

Distribution Sales

$

72,061

$

80,096

$

8,035

)

(10.0

%)

Cost of Sales

56,638

61,104

(4,466

)

(7.3

%)

Gross Profit

$

15,423

$

18,992

$

(3,569

)

(18.8

%)

Gross Margin

21.4

%

23.7

%

Selling, Marketing & Warehouse Expenses

$

7,802

$

8,478

$

(676

)

(8.0

%)

General and Administrative Expenses

6,989

5,336

1,653

31.0

%

Operating Income

$

632

$

5,178

$

(4,546

)

(88.3

%)

% of Sales

0.9

%

6.5

%

Change

TOTAL

FY 2021 YTD

FY 2020 YTD

$'s

%

Total Revenue

$

173,335

$

173,099

$

236

0.1

%

Total Cost of Revenue

127,217

130,621

(3,404

)

(2.6

%)

Gross Profit

$

46,118

$

42,478

$

3,640

8.6

%

Gross Margin

26.6

%

24.5

%

Selling, Marketing & Warehouse Expenses

$

17,743

$

17,985

$

(242

)

(1.3

%)

General and Administrative Expenses

17,302

13,643

3,659

26.8

%

Operating Income

$

11,073

$

10,850

$

223

2.1

%

% of Revenue

6.4

%

6.3

%

View source version on businesswire.com: https://www.businesswire.com/news/home/20210518006010/en/

Contacts

Mark A. Doheny, Chief Financial Officer
Phone: (585) 563-5766
Email: mark.doheny@transcat.com

Deborah K. Pawlowski, Investor Relations
Phone: (716) 843-3908
Email: dpawlowski@keiadvisors.com